Healthcare Game-Changers: Innovations Shaping the Industry
In an industry that develops as quickly as healthcare, it’s difficult to know which innovations will lead to lasting change and which will be promptly replaced by the next exciti
Selecting the Right Investment Bank to Take Your Company Public
Taking a company public is a momentous milestone in the growth of a life science or healthcare company. Whether or not an initial public offering (IPO) is in your company’s futur
iBIO IndEx 2017: Amid Political Uncertainty, Industry Collaboration Is Key to Advancement
The effects of technological advances and an uncertain political environment were the focus of this year’s Illinois Biotechnology Innovation Organization (iBIO) Industry Expo (In
Europe to Issue New Safety Regulations for Medical Devices and Diagnostics: What You Need to Know
Want to find a place in the EU market for your IVD/med device? You’ll need to get through some new hoops first! As the first quarter of 2017 drew to a close, the in vitro diagnos
Gene Editing with CRISPR Technology: Keeping the Focus on Patients
Ever since a proof-of-concept paper was published in 2012, the gene-editing technique CRISPR-Cas9 has been making waves as a major scientific breakthrough—one that has captured t
Global Science Marketing: Expanding Your Presence Across the Globe
With online communities and communication across labs increasing, science companies find themselves crossing national borders to establish an international presence. There are scie
What Do the Next 7 Years Bring for Medtech?
The past year has seen some shake-up in world news, but it remains to be seen precisely how developments will affect the medtech industry moving forward. Significant considerations
Going to BIO? Top 5 Things to Do While You’re in San Francisco
The BIO International Convention brings together more 15,000 biotechnology and pharma leaders for several days of intensive networking to discover new opportunities and promising p
A Bright Future for Pharma and Biotech in 2016
Before 2016 even officially kicked off, the life sciences industry received an early present to the tune of $32 billion. The House and Senate approved the 2016 spending bill, inclu
What You Cared About in 2015
As the year closes, one can’t help but reflect. So, we take a look back at our most popular blog posts from 2015. During the last 12 months, Chempetitive Group’s Chemunity blog